Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2023-01-10 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
关于控股子公司重组人生长激素注射液新适应症获得批准的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Changchun High & New Technology Industry Group Co., Ltd. regarding the approval of a new indication for a drug produced by its subsidiary. It includes a regulatory approval notice from the National Medical Products Administration and a risk warning to investors. The document is brief (669 characters) and does not contain financial data, financial statements, or detailed management discussion. It is an official announcement about a product approval, not a financial report or detailed investor presentation. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-01-10 Chinese
2022年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2022 second extraordinary general meeting of shareholders of Changchun High-tech Industry (Group) Co., Ltd. It includes information about the meeting date, voting methods, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official results of shareholder votes at a general meeting, including approval of stock repurchase cancellation and amendments to the company bylaws. There is no financial data, no presentation or report attached, and the document is not a proxy solicitation or management report. The document fits the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is 2210 characters, which is consistent with a voting results announcement rather than a full report. Therefore, the correct classification is DVA with high confidence.
2022-12-29 Chinese
北京大成（长春）律师事务所关于长春高新技术产业（集团）股份有限公司2022年第二次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality of the procedures and validity of the resolutions passed at the 2022 second extraordinary general meeting (临时股东大会) of Changchun High-tech Industrial (Group) Co., Ltd. It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or management discussion but focuses on legal compliance and voting results. It is not a full annual or interim report, nor an earnings release or management report. It is not a proxy solicitation or voting results announcement per se, but a legal opinion on the meeting's legality. Given the nature of the document as a legal opinion on a shareholders meeting, it best fits under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory or compliance documents that do not fit other categories.
2022-12-29 Chinese
关于回购注销部分限制性股票减少注册资本暨通知债权人的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Changchun High-tech Industry Group Co., Ltd. regarding the repurchase and cancellation of part of its restricted shares, which leads to a reduction in registered capital. It includes details about the board and shareholder meetings approving the repurchase, the reduction in share capital, and a notification to creditors about their rights to claim debts or request guarantees within 45 days. The document is a formal public notice about a capital change event and related creditor notification, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive information about the transaction and legal compliance. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is short but contains detailed information about the capital change event, not just a brief notice or reference to a report.
2022-12-29 Chinese
关于2022年限制性股票与股票期权激励计划部分股票期权注销完成的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the completion of cancellation of certain stock options under the company's 2022 restricted stock and stock option incentive plan. It details board meeting approvals, regulatory compliance, and confirms that the cancellation does not affect the company's capital structure. The document is a formal announcement about a transaction in the company's own shares (stock options cancellation). It is not a full financial report, earnings release, or management discussion. It fits the category of Transaction in Own Shares (POS) as it reports on the company's buyback or cancellation of its own stock options.
2022-12-27 Chinese
关于召开2022年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2022 second extraordinary general meeting of shareholders for Changchun High-tech Industry Group Co., Ltd. It includes information about the meeting date, voting procedures, agenda items (such as stock repurchase and amendment of company articles), registration details, and proxy voting instructions. There is no financial data or report content, but rather a formal announcement and procedural information for a shareholder meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document length is under 5,000 characters and it is not a report publication announcement or regulatory filing. Therefore, the classification is PSI with high confidence.
2022-12-13 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.